DK
David Kirske
Chief Financial Officer

David Kirske insider trades: X4 Pharmaceuticals (XFOR) stock sales

Chief Financial Officer, X4 Pharmaceuticals Last trade Oct 1, 2026 21 Form 4 filings
$143K
Sold, last 12 months
3 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2022
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where David reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Oct 1, 2026XFOR↓ Sell$34K
Jun 30, 2026XFOR↓ Sell$36K
May 12, 2026XFOR↓ Sell$73K
Jan 3, 2023CTIC↓ Sell$325K
Oct 4, 2022CTIC↓ Sell$13K
Oct 3, 2022CTIC↓ Sell$853K
Sep 16, 2022CTIC↓ Sell$136K
Jun 17, 2022CTIC↓ Sell$373K
Jun 14, 2022CTIC↓ Sell$55K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other XFOR insiders

Open-market trades in the last 12 months

About David Kirske's insider trades

David Kirske is Chief Financial Officer at X4 Pharmaceuticals (XFOR). Since Jun 14, 2022, David has reported no open-market purchases and 9 sales worth $1.9M on SEC Form 4. In the last 12 months: 3 sales ($143K).

Their filings also include grants and awards (13 filings), option exercises (6 filings), other transactions (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every XFOR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.